Open Medicine
(Jan 2021)
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Malkan Umit Yavuz,
Demiroglu Haluk,
Buyukasik Yahya,
Karatas Ayse,
Aladag Elifcan,
Goker Hakan
Affiliations
Malkan Umit Yavuz
Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
Demiroglu Haluk
Department of Hematology, Faculty of Medicine, Hacettepe University, 06230, Ankara, Turkey
Buyukasik Yahya
Department of Hematology, Faculty of Medicine, Hacettepe University, 06230, Ankara, Turkey
Karatas Ayse
Department of Hematology, Faculty of Medicine, Hacettepe University, 06230, Ankara, Turkey
Aladag Elifcan
Department of Hematology, Faculty of Medicine, Hacettepe University, 06230, Ankara, Turkey
Goker Hakan
Department of Hematology, Faculty of Medicine, Hacettepe University, 06230, Ankara, Turkey
DOI
https://doi.org/10.1515/med-2021-0216
Journal volume & issue
Vol. 16,
no. 1
Abstract
Read online
Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.
Keywords
WeChat QR code
Close
